cytosine has been researched along with Cervix Dysplasia in 5 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "No clinically significant hematological/biochemical abnormalities or serious adverse events (SAE) were reported, although 6 mild to moderate adverse events (AE) occurred in relation to the study drug: 1 flu-like syndrome and 5 local AEs." | 2.87 | Safety and tolerance of cidofovir as a 2% gel for local application in high-grade cervical intraepithelial neoplasia: A phase 1 investigation. ( Bossens, M; De Maertelaer, V; Evrard, B; Frankenne, F; Hubert, P; Jost, M; Simon, P; Snoeck, R; Van Pachterbeke, C, 2018) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (80.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bossens, M | 4 |
| Jost, M | 1 |
| Van Pachterbeke, C | 2 |
| De Maertelaer, V | 1 |
| Simon, P | 1 |
| Frankenne, F | 1 |
| Hubert, P | 1 |
| Evrard, B | 1 |
| Snoeck, R | 4 |
| Bucella, D | 1 |
| Rozenberg, S | 1 |
| Manigart, Y | 1 |
| Gilles, C | 1 |
| Larsimont, D | 1 |
| Vanden Houte, K | 1 |
| Reynders, M | 1 |
| Noel, JC | 1 |
| Muller, C | 1 |
| De Clercq, E | 1 |
| Koonsaeng, S | 1 |
| Verschraegen, C | 1 |
| Freedman, R | 1 |
| Kudelka, A | 1 |
| Kavanagh, J | 1 |
| Sittisomwong, T | 1 |
| DeClercq, E | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| TOPical Imiquimod Treatment of High-grade Cervical Intraepithelial Neoplasm: a Randomized Controlled Trial.[NCT02329171] | Phase 3 | 9 participants (Actual) | Interventional | 2014-12-31 | Terminated (stopped due to Insufficient number of participants.) | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
3 trials available for cytosine and Cervix Dysplasia
| Article | Year |
|---|---|
Safety and tolerance of cidofovir as a 2% gel for local application in high-grade cervical intraepithelial neoplasia: A phase 1 investigation.
Topics: Administration, Topical; Adult; Antiviral Agents; C-Reactive Protein; Cidofovir; Cytosine; Female; F | 2018 |
Topical treatment of CIN 2+ by cidofovir: results of a phase II, double-blind, prospective, placebo-controlled study.
Topics: Administration, Topical; Adult; Antineoplastic Agents; Cidofovir; Combined Modality Therapy; Conizat | 2009 |
Cidofovir, a new approach for the treatment of cervix intraepithelial neoplasia grade III (CIN III).
Topics: Adult; Antiviral Agents; Biopsy; Cervix Uteri; Cidofovir; Conization; Cytosine; Female; Humans; Immu | 2000 |
2 other studies available for cytosine and Cervix Dysplasia
| Article | Year |
|---|---|
Anti-cancer agents. Will cidofovir be useful against cervical lesions?
Topics: Adult; Antiviral Agents; Cidofovir; Cytosine; Female; Humans; Organophosphonates; Organophosphorus C | 2000 |
Successful treatment of recurrent vulvar intraepithelial neoplasia resistant to interferon and isotretinoin with cidofovir.
Topics: Administration, Oral; Administration, Topical; Adult; Antineoplastic Agents; Carcinoma in Situ; Cido | 2001 |